Abstract

Vedolizumab, a humanized monoclonal antibody to the α4β7 integrin, reduces lymphocyte trafficking to the intestine.

Tags

Adverse Effects, Antibodies, Crohn's Disease, Drug Therapy, Gastrointestinal Agents, Monoclonal, therapeutic use, Ulcerative Colitis

Read More